These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11383716

  • 1. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
    Rizzi D, Bigoni R, Rizzi A, Jenck F, Wichmann J, Guerrini R, Regoli D, Calo G.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):551-5. PubMed ID: 11383716
    [Abstract] [Full Text] [Related]

  • 2. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
    Bigoni R, Rizzi A, Rizzi D, Becker JA, Kieffer BL, Simonin F, Regoli D, Calo G.
    Life Sci; 2000 Dec 01; 68(2):233-9. PubMed ID: 11191640
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of nociceptin receptor: an in vitro study.
    Calò G, Rizzi A, Bodin M, Neugebauer W, Salvadori S, Guerrini R, Bianchi C, Regoli D.
    Can J Physiol Pharmacol; 1997 Jun 01; 75(6):713-8. PubMed ID: 9276153
    [Abstract] [Full Text] [Related]

  • 4. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
    Rizzi D, Rizzi A, Bigoni R, Camarda V, Marzola G, Guerrini R, De Risi C, Regoli D, Calo' G.
    J Pharmacol Exp Ther; 2002 Jan 01; 300(1):57-63. PubMed ID: 11752097
    [Abstract] [Full Text] [Related]

  • 5. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
    Bigoni R, Calo' G, Rizzi A, Guerrini R, De Risi C, Hashimoto Y, Hashiba E, Lambert DG, Regoli D.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 01; 361(5):565-8. PubMed ID: 10832612
    [Abstract] [Full Text] [Related]

  • 6. Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors.
    Bigoni R, Caò G, Rizzi A, Okawa H, Regoli D, Smart D, Lambert DG.
    Can J Physiol Pharmacol; 2002 May 01; 80(5):407-12. PubMed ID: 12056546
    [Abstract] [Full Text] [Related]

  • 7. A new selective antagonist of the nociceptin receptor.
    Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S, Regoli D.
    Br J Pharmacol; 1998 Jan 01; 123(2):163-5. PubMed ID: 9489602
    [Abstract] [Full Text] [Related]

  • 8. Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens.
    Bigoni R, Calo G, Guerrini R, Strupish JW, Rowbotham DJ, Lambert DG.
    Br J Clin Pharmacol; 2001 Apr 01; 51(4):355-8. PubMed ID: 11318773
    [Abstract] [Full Text] [Related]

  • 9. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR, Glen T, Davies MR, Paterson SJ, Corbett AD.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):217-23. PubMed ID: 10607879
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
    Varani K, Rizzi A, Calo G, Bigoni R, Toth G, Guerrini R, Gessi S, Salvadori S, Borea PA, Regoli D.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep 03; 360(3):270-7. PubMed ID: 10543428
    [Abstract] [Full Text] [Related]

  • 11. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL, Chang M, Dong SL, Li W, Han RW, Fu GX, Chen Q, Wang R.
    Regul Pept; 2006 May 15; 134(2-3):75-81. PubMed ID: 16516988
    [Abstract] [Full Text] [Related]

  • 12. Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.
    Bigoni R, Giuliani S, Calo' G, Rizzi A, Guerrini R, Salvadori S, Regoli D, Maggi CA.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar 15; 359(3):160-7. PubMed ID: 10208302
    [Abstract] [Full Text] [Related]

  • 13. Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor.
    Hashiba E, Harrison C, Galo' G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan 15; 363(1):28-33. PubMed ID: 11191833
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
    Okawa H, Nicol B, Bigoni R, Hirst RA, Calo G, Guerrini R, Rowbotham DJ, Smart D, McKnight AT, Lambert DG.
    Br J Pharmacol; 1999 May 15; 127(1):123-30. PubMed ID: 10369464
    [Abstract] [Full Text] [Related]

  • 15. Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist.
    Guerrini R, Calo' G, Bigoni R, Rizzi D, Regoli D, Salvadori S.
    J Pept Res; 2001 Mar 15; 57(3):215-22. PubMed ID: 11298922
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 15; 368(6):528-37. PubMed ID: 14598020
    [Abstract] [Full Text] [Related]

  • 17. Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.
    Goeldner C, Spooren W, Wichmann J, Prinssen EP.
    Psychopharmacology (Berl); 2012 Jul 15; 222(2):203-14. PubMed ID: 22249359
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G.
    J Pharmacol Exp Ther; 2007 Jun 15; 321(3):961-7. PubMed ID: 17329552
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G.
    Peptides; 2007 Jun 15; 28(6):1240-51. PubMed ID: 17532097
    [Abstract] [Full Text] [Related]

  • 20. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R, Caló G, Bigoni R, Rizzi A, Varani K, Toth G, Gessi S, Hashiba E, Hashimoto Y, Lambert DG, Borea PA, Tomatis R, Salvadori S, Regoli D.
    J Med Chem; 2000 Jul 27; 43(15):2805-13. PubMed ID: 10956188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.